Who
Manu Ohri
Director
Company insider
Files Form 4 as: Director, AXIL Brands; CFO & Secretary, GT Biopharma.
In numbers
- Trades disclosed
- 13
- Buys
- 1
- Sells
- 0
- Bought
- $25K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 15 Jul 2022
- Last trade
- 15 Jan 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jan 2026filed 4 Mar 2026 | AXIL AXIL BrandsHousehold & Personal Care | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 15 Jan 2026filed 4 Mar 2026 | AXIL AXIL BrandsHousehold & Personal Care | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 13 Jan 2025filed 13 Jan 2025 | AXIL AXIL BrandsHousehold & Personal Care | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 14 Feb 2024filed 20 Feb 2024 | AXIL AXIL BrandsHousehold & Personal Care | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 11 Aug 2023filed 15 Aug 2023 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Code A | $58K200,000 at $0.29 | filing |
| 11 Aug 2023filed 15 Aug 2023 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Code J | $58K200,000 at $0.29 | filing |
| 11 Aug 2023filed 15 Aug 2023 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Code J | $58K200,000 at $0.29 | filing |
| 6 Apr 2023filed 10 Apr 2023 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Bought | $25K50,000 at $0.50 | filing |
| 27 Jan 2023filed 1 Feb 2023 | GTBP GT Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 15 Jul 2022filed 19 Jul 2022 | GTBP GT Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —200,000 at $0.00 | filing |
| 15 Jul 2022filed 19 Jul 2022 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Jul 2022filed 19 Jul 2022 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Code J | —100,000 at $0.00 | filing |
| 15 Jul 2022filed 19 Jul 2022 | GTBP GT BiopharmaBiotechnology | SEC FORM 4 Code J | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.